Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Partnership

15 Feb 2007 09:04

Plant Health Care PLC15 February 2007 15 February 2007 PLANT HEALTH CARE FORMS PARTNERSHIP WITH AMERICAN SOYBEAN ASSOCIATION Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc("Plant Health Care") and The American Soybean Association ("ASA") announce the2007 "N-Hibit Partnership" field trail programme that will evaluate PlantHealth Care's N-Hibit Seed Treatment, as a tool to lower Soyabean Cyst Nematode(SCN) and improve soybean plant health, during the 2007 growing season. The ASA represents a significant majority of the US soybean growers who plantedsome 75 million acres of soybeans in the US last year. N-Hibit is a dry material that is not a restricted use product. It is easy toapply, has an excellent safety profile and leaves no residuals in the water,soil or on plants. University field research has shown that N-Hibit reduces SCN eggs significantly.Other replicated and commercial research trails have also shown that N-Hibitincreases root and plant growth and increases soybean yield by about 6.5 percent per acre. The active ingredient in N-Hibit and other Harp-N-Tek products is harpinprotein, which is produced by disease causing bacteria that attack plants.Harp-N-Tek products do not contain pathogens, but cause the plant to respond asthough being attacked. Harpin proteins do not enter the plant. They bind withthe plant's external harpin protein receptors, which are present on seed, aswell as foliage. This turns on the plant's natural self defence and growthsystems. Then the harpin proteins harmlessly disintegrate ASA Vice President, Rob Joslin said: "ASA views this field trial program as anopportunity for its members to maximize soybean yield and profitability, andreduce the threat of SCN damage. We believe soybean growers will want to conducttheir own on-farm trials to determine results with N-Hibit on a commercial scaleunder their own growing conditions and management systems to help document theperformance of this seed treatment." John Brady CEO of Plant Health Care said: "We are delighted to be working withthe ASA on the Field Trail Programme for N-Hibit, as it will show soybeangrowers across the US that this product is highly effective and can help themincrease yield per acre and hence their profits. This is the best introductionto the soybean industry and as a result of this association we fully expectsignificant penetration into this huge market by 2008/2009". For further information contact: Plant Health Care plcJohn Brady, CEO; phone: +1 603 525 3702E-Mail: jabrady@planthealthcare.com Tavistock ComunicationsJeremy Carey/Matt Ridsdale, phone: +44 20 7920 3150E-Mail: jcarey@tavistock.co.uk, mridsdale@tavistock.co.uk Notes to Editors: About Plant Health Care:Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Nov 20193:56 pmRNSHolding(s) in Company
6th Nov 201912:57 pmRNSInvestment in Company by Ospraie Ag Science LLC
30th Oct 20197:00 amRNSAppointment of new Board Directors
3rd Oct 20192:50 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSInterim Report ended 30 June 2019
9th Sep 20197:00 amRNSPilot production of PREtec peptides
19th Aug 20197:00 amRNSBlock listing Interim Review
15th Aug 20197:00 amRNSProgress with PREtec field trials in Brazil
5th Aug 20195:18 pmRNSHolding(s) in Company
25th Jun 20197:00 amRNSNew Distribution Agreement with Wilbur-Ellis
12th Jun 201911:05 amRNSResult of AGM
30th Apr 20194:19 pmRNSAnnual Report & Accounts and AGM Notice Published
10th Apr 20197:00 amRNSResults for the year ended 31 December 2018
27th Mar 20193:41 pmRNSHolding(s) in Company
28th Feb 20197:00 amRNSNew Technology Update
19th Feb 20197:00 amRNSBlock listing Interim Review
29th Jan 20197:00 amRNSTrading Statement
24th Jan 20195:58 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSTrading Statement
28th Nov 20187:00 amRNSNew Technology Update
21st Nov 20187:00 amRNSPlant Health Care ProAct® Wins Top Industry Award
19th Nov 20187:00 amRNSPlant Health Care to present at Mello London
14th Nov 20187:00 amRNSPositive Developments with Harpin
8th Nov 20187:00 amRNSChange of Adviser
5th Nov 20187:00 amRNSHolding(s) in Company
18th Sep 20187:00 amRNSInterim Report ended 30 June 2018
12th Sep 20187:00 amRNSUS Announces Harpin aß Product Launch in Corn
20th Aug 20187:00 amRNSBlock listing Interim Review
30th Jul 20187:00 amRNSUpdate on sugarcane in Brazil
16th Jul 20187:00 amRNSTrading Statement
6th Jun 20182:39 pmRNSHolding(s) in Company
6th Jun 201811:14 amRNSResult of AGM
30th May 20187:00 amRNSGrant of Options
4th May 20185:59 pmRNSHolding(s) in Company
30th Apr 20183:11 pmRNSPublication of Annual Report and Notice of AGM
10th Apr 20187:00 amRNSResults for the year ended 31 December 2017
8th Mar 20187:00 amRNSBlock listing Interim Review
7th Mar 20183:07 pmRNSHolding(s) in Company
7th Mar 20183:06 pmRNSHolding(s) in Company
7th Mar 20183:02 pmRNSHolding(s) in Company
2nd Mar 20185:48 pmRNSHolding(s) in Company
27th Feb 20184:12 pmRNSResult of Placing and Subscription
27th Feb 20187:00 amRNSProposed Placing and Subscription
24th Jan 20187:00 amRNSTrading Statement
12th Dec 20177:00 amRNSNew Technology Update
8th Dec 20174:35 pmRNSPrice Monitoring Extension
6th Dec 20174:40 pmRNSSecond Price Monitoring Extn
6th Dec 20174:35 pmRNSPrice Monitoring Extension
18th Sep 20177:00 amRNSHalf-year Report
21st Aug 20177:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.